Allogenic islet cells (University of Chicago)

N/A

Report date: 2023/03/09 10:54:37

Base Information

Drug NameAllogenic islet cells (University of Chicago)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Pancreatic islet cell therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesThe University Of Chicago

China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Chicago

Inactive CompaniesN/A

Active IndicationsDiabetes Mellitus, Type 1

Inactive IndicationsN/A

Other Information

ATC CodeN/A